Fresenius SE KGaA (XSWX:FRE) Other Income (Expense): CHF319 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:FRE Fresenius SE & Co KGaA XSWX:FRE
67 GF Score
Price CHF39.86
GF Value CHF33.48
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Other Income (Expense)?

Fresenius SE KGaA XSWX:FRE 67 Other Income (Expense) is CHF319 Mil as of Mar. 2026. GuruFocus rates XSWX:FRE with a GF Score™ of 67/100 and a GF Value™ of CHF33.48 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Fresenius SE KGaA's other income expense for the Fresenius SE KGaA's pretax income for the three months ended in Mar. 2026 was CHF31 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2026 was CHF319 Mil.

Fresenius SE KGaA  (XSWX:FRE) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Fresenius SE KGaA Other Income (Expense) Historical Data

* Premium members only.

The historical data trend for Fresenius SE KGaA's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius SE KGaA Other Income (Expense) Chart

Fresenius SE KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 -11.32 35.48 304.76

Fresenius SE KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.19 35.64 61.67 190.92 30.95
XSWX:FRE
67GF Score
Fresenius SE & Co KGaA XSWX:FRE
Other Income (Expense) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius SE KGaA Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF319 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Income (Expense) →
What does a Other Income (Expense) of CHF319 Mil mean?
Fresenius SE KGaA (XSWX:FRE) has a Other Income (Expense) of CHF319 Mil as of Mar. 2026. Other income and expenses that a company records on the income statement. View historical data on Fresenius SE KGaA and its competitors.
Is Fresenius SE KGaA's Other Income (Expense) too high?
Fresenius SE KGaA's current Other Income (Expense) is CHF319 Mil. Overall, Fresenius SE KGaA has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Other Income (Expense) compare to HCA and THC?
Fresenius SE KGaA's Other Income (Expense) of CHF319 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Income (Expense) for a Healthcare Providers & Services company?
A good Other Income (Expense) depends on the Healthcare Providers & Services industry context. However, Other Income (Expense) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Income (Expense) mean?
A high Other Income (Expense) can signal that a stock is expensive relative to its fundamentals. Other income and expenses that a company records on the income statement. View historical data on Fresenius SE KGaA and its competitors. Fresenius SE KGaA's current Other Income (Expense) is CHF319 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF33.48, compared to a current price of CHF39.86 — trading 19.1% above its estimated fair value. The current Other Income (Expense) is CHF319 Mil. Fresenius SE KGaA's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Income (Expense) calculated?
Other Income (Expense) is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Other Income (Expense) is CHF319 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of CHF39.86 is trading 19.1% above its estimated GF Value™ of CHF33.48. GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.

Key valuation signals for XSWX:FRE:

  • Other Income (Expense): CHF319 Mil
  • GF Value™: CHF33.48 vs. price of CHF39.86 (19.1% above fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
67GF Score

Get the complete analysis for XSWX:FRE

Other Income (Expense) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF39.86
Price
CHF33.48
GF Value